Share Price and Basic Stock Data
Last Updated: October 7, 2025, 11:27 pm
| PEG Ratio | 0.40 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Alkosign Ltd operates in an undisclosed industry with a current share price of ₹80.0 and a market capitalization of ₹86.3 Cr. The company’s quarterly sales trends show a consistent performance, with a net profit of ₹3.77 Cr. Operating profit margin (OPM) stands at 12.53%, indicating stable operational efficiency. The expense management reflects a balanced approach, contributing to sustained profitability over time.
Profitability and Efficiency Metrics
Alkosign Ltd’s Return on Equity (ROE) is at 12.0%, while Return on Capital Employed (ROCE) stands at 12.8%, showcasing decent returns for investors. The Interest Coverage Ratio (ICR) of 7.47x indicates the company’s ability to meet interest obligations comfortably. A Cash Conversion Cycle (CCC) of 240.36 days suggests efficient management of working capital. These metrics align with sector norms, indicating a healthy profitability and efficiency profile.
Balance Sheet Strength and Financial Ratios
The company holds reserves worth ₹25.79 Cr, providing a cushion for future investments and expansions. With borrowings amounting to ₹12.55 Cr, Alkosign Ltd maintains a balanced debt-equity ratio. The Price-to-Book Value (P/BV) ratio of 2.09x implies a reasonable valuation compared to industry peers. The healthy Interest Coverage Ratio (ICR) of 7.47x signifies a strong balance sheet and liquidity position.
Shareholding Pattern and Investor Confidence
Promoters hold a significant stake of 41.89%, indicating a vested interest in the company’s performance. Foreign Institutional Investors (FIIs) have a 9.94% stake, reflecting moderate interest from global investors. The public shareholding stands at 48.15%, distributed among 662 shareholders. The consistent holding pattern signifies stable investor confidence, influencing the company’s valuation and market perception positively.
Outlook, Risks, and Final Insight
Looking ahead, Alkosign Ltd’s growth prospects appear promising, supported by a strong balance sheet and efficient operational performance. Key growth drivers include expanding market presence and product innovation. However, risks such as economic downturns and industry competition could pose challenges. Strengthening operational resilience and diversifying revenue streams will be crucial for navigating potential risks. In conclusion, Alkosign Ltd’s sound financial metrics and strategic positioning provide a solid foundation for future growth, making it an attractive prospect for investors seeking stability and potential returns.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Alkosign Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujarat Metallic Coal & Coke Ltd | 5.94 Cr. | 30.0 | / | 77.6 | 0.00 % | 0.37 % | 2.00 % | 100 | |
| Gensol Engineering Ltd | 152 Cr. | 39.4 | 875/31.9 | 1.48 | 155 | 0.00 % | 14.3 % | 22.4 % | 10.0 |
| Fusion Micro Finance Ltd | 2,636 Cr. | 194 | 227/124 | 101 | 0.00 % | 2.96 % | 54.5 % | 10.0 | |
| Five X Tradecom Ltd | 0.99 Cr. | 0.48 | / | 9.35 | 0.00 % | 0.00 % | 0.00 % | 10.0 | |
| East West Holdings Ltd | 59.2 Cr. | 4.64 | 8.90/4.53 | 5.12 | 0.00 % | 6.98 % | 0.86 % | 2.00 | |
| Industry Average | 7,566.48 Cr | 263.18 | 398.29 | 100.80 | 0.22% | 11.73% | 22.92% | 9.18 |
Quarterly Result
| Metric | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Sales | 4.03 | 6.13 | 9.11 | 12.27 | 21.25 | 14.43 | 27.90 | 23.63 |
| Expenses | 3.38 | 5.91 | 8.18 | 10.38 | 12.65 | 18.52 | 23.06 | 20.67 |
| Operating Profit | 0.65 | 0.22 | 0.93 | 1.89 | 8.60 | -4.09 | 4.84 | 2.96 |
| OPM % | 16.13% | 3.59% | 10.21% | 15.40% | 40.47% | -28.34% | 17.35% | 12.53% |
| Other Income | -0.00 | 0.06 | 0.03 | 0.22 | 0.04 | 0.24 | 0.15 | 0.16 |
| Interest | 0.40 | 0.44 | 0.64 | 0.87 | 0.45 | 1.22 | 0.51 | 0.57 |
| Depreciation | 0.69 | 0.97 | 0.94 | 1.00 | 1.20 | 1.25 | 1.17 | 1.25 |
| Profit before tax | -0.44 | -1.13 | -0.62 | 0.24 | 6.99 | -6.32 | 3.31 | 1.30 |
| Tax % | -6.82% | -15.04% | 1.61% | 25.00% | 17.02% | -20.73% | -0.00% | 65.38% |
| Net Profit | -0.41 | -0.96 | -0.63 | 0.18 | 5.80 | -5.02 | 3.31 | 0.46 |
| EPS in Rs | -1.17 | -0.77 | 0.22 | 5.37 | -4.65 | 3.06 | 0.43 |
Last Updated: August 20, 2025, 12:05 am
Below is a detailed analysis of the quarterly data for Alkosign Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 23.63 Cr.. The value appears to be declining and may need further review. It has decreased from 27.90 Cr. (Sep 2024) to 23.63 Cr., marking a decrease of 4.27 Cr..
- For Expenses, as of Mar 2025, the value is 20.67 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 23.06 Cr. (Sep 2024) to 20.67 Cr., marking a decrease of 2.39 Cr..
- For Operating Profit, as of Mar 2025, the value is 2.96 Cr.. The value appears to be declining and may need further review. It has decreased from 4.84 Cr. (Sep 2024) to 2.96 Cr., marking a decrease of 1.88 Cr..
- For OPM %, as of Mar 2025, the value is 12.53%. The value appears to be declining and may need further review. It has decreased from 17.35% (Sep 2024) to 12.53%, marking a decrease of 4.82%.
- For Other Income, as of Mar 2025, the value is 0.16 Cr.. The value appears strong and on an upward trend. It has increased from 0.15 Cr. (Sep 2024) to 0.16 Cr., marking an increase of 0.01 Cr..
- For Interest, as of Mar 2025, the value is 0.57 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.51 Cr. (Sep 2024) to 0.57 Cr., marking an increase of 0.06 Cr..
- For Depreciation, as of Mar 2025, the value is 1.25 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.17 Cr. (Sep 2024) to 1.25 Cr., marking an increase of 0.08 Cr..
- For Profit before tax, as of Mar 2025, the value is 1.30 Cr.. The value appears to be declining and may need further review. It has decreased from 3.31 Cr. (Sep 2024) to 1.30 Cr., marking a decrease of 2.01 Cr..
- For Tax %, as of Mar 2025, the value is 65.38%. The value appears to be increasing, which may not be favorable. It has increased from 0.00% (Sep 2024) to 65.38%, marking an increase of 65.38%.
- For Net Profit, as of Mar 2025, the value is 0.46 Cr.. The value appears to be declining and may need further review. It has decreased from 3.31 Cr. (Sep 2024) to 0.46 Cr., marking a decrease of 2.85 Cr..
- For EPS in Rs, as of Mar 2025, the value is 0.43. The value appears to be declining and may need further review. It has decreased from 3.06 (Sep 2024) to 0.43, marking a decrease of 2.63.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: July 22, 2025, 2:36 pm
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Sales | 13.24 | 13.24 | 10.16 | 21.38 | 35.69 | 51.53 |
| Expenses | 11.85 | 11.85 | 9.28 | 18.55 | 31.18 | 43.72 |
| Operating Profit | 1.39 | 1.39 | 0.88 | 2.83 | 4.51 | 7.81 |
| OPM % | 10.50% | 10.50% | 8.66% | 13.24% | 12.64% | 15.16% |
| Other Income | 0.03 | 0.03 | 0.05 | 0.25 | 0.28 | 0.32 |
| Interest | 0.31 | 0.31 | 0.84 | 1.51 | 1.67 | 1.09 |
| Depreciation | 0.20 | 0.20 | 1.66 | 1.95 | 2.45 | 2.42 |
| Profit before tax | 0.91 | 0.91 | -1.57 | -0.38 | 0.67 | 4.62 |
| Tax % | 27.47% | 27.47% | -12.74% | 21.05% | -16.42% | 18.40% |
| Net Profit | 0.66 | 0.66 | -1.38 | -0.46 | 0.78 | 3.77 |
| EPS in Rs | -1.68 | -0.56 | 0.72 | 3.49 | ||
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 9.23% | 0.00% |
YoY Net Profit Growth
| Year | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 0.00% | -309.09% | 66.67% | 269.57% | 383.33% |
| Change in YoY Net Profit Growth (%) | 0.00% | -309.09% | 375.76% | 202.90% | 113.77% |
Alkosign Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 5 years from 2020-2021 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 31% |
| 3 Years: | 72% |
| TTM: | 44% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 42% |
| 3 Years: | 68% |
| TTM: | 409% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 22% |
| 1 Year: | -9% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 5% |
| 3 Years: | 6% |
| Last Year: | 12% |
Last Updated: September 5, 2025, 2:11 pm
Balance Sheet
Last Updated: October 10, 2025, 3:24 pm
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Equity Capital | 0.01 | 0.01 | 5.45 | 5.45 | 7.20 | 7.20 |
| Reserves | 0.66 | 0.66 | 7.17 | 6.71 | 22.02 | 25.79 |
| Borrowings | 20.47 | 20.47 | 16.03 | 20.40 | 13.85 | 12.55 |
| Other Liabilities | 2.52 | 2.37 | 0.88 | 2.23 | 6.76 | 5.51 |
| Total Liabilities | 23.66 | 23.51 | 29.53 | 34.79 | 49.83 | 51.05 |
| Fixed Assets | 1.56 | 1.56 | 15.95 | 18.35 | 16.93 | 16.31 |
| CWIP | 14.28 | 14.28 | 0.00 | 0.00 | 0.61 | 0.54 |
| Investments | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 | 0.00 |
| Other Assets | 7.72 | 7.57 | 13.48 | 16.34 | 32.19 | 34.20 |
| Total Assets | 23.66 | 23.51 | 29.53 | 34.79 | 49.83 | 51.05 |
Below is a detailed analysis of the balance sheet data for Alkosign Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 7.20 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 7.20 Cr..
- For Reserves, as of Mar 2025, the value is 25.79 Cr.. The value appears strong and on an upward trend. It has increased from 22.02 Cr. (Mar 2024) to 25.79 Cr., marking an increase of 3.77 Cr..
- For Borrowings, as of Mar 2025, the value is 12.55 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 13.85 Cr. (Mar 2024) to 12.55 Cr., marking a decrease of 1.30 Cr..
- For Other Liabilities, as of Mar 2025, the value is 5.51 Cr.. The value appears to be improving (decreasing). It has decreased from 6.76 Cr. (Mar 2024) to 5.51 Cr., marking a decrease of 1.25 Cr..
- For Total Liabilities, as of Mar 2025, the value is 51.05 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 49.83 Cr. (Mar 2024) to 51.05 Cr., marking an increase of 1.22 Cr..
- For Fixed Assets, as of Mar 2025, the value is 16.31 Cr.. The value appears to be declining and may need further review. It has decreased from 16.93 Cr. (Mar 2024) to 16.31 Cr., marking a decrease of 0.62 Cr..
- For CWIP, as of Mar 2025, the value is 0.54 Cr.. The value appears to be declining and may need further review. It has decreased from 0.61 Cr. (Mar 2024) to 0.54 Cr., marking a decrease of 0.07 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.10 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 0.10 Cr..
- For Other Assets, as of Mar 2025, the value is 34.20 Cr.. The value appears strong and on an upward trend. It has increased from 32.19 Cr. (Mar 2024) to 34.20 Cr., marking an increase of 2.01 Cr..
- For Total Assets, as of Mar 2025, the value is 51.05 Cr.. The value appears strong and on an upward trend. It has increased from 49.83 Cr. (Mar 2024) to 51.05 Cr., marking an increase of 1.22 Cr..
Notably, the Reserves (25.79 Cr.) exceed the Borrowings (12.55 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Free Cash Flow | -19.08 | -19.08 | -15.15 | -17.57 | -9.34 | -4.74 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Debtor Days | 137.56 | 137.56 | 83.71 | 47.12 | 57.58 | 84.57 |
| Inventory Days | 115.21 | 115.21 | 202.07 | 267.67 | 278.07 | 203.40 |
| Days Payable | 98.90 | 98.90 | 31.43 | 32.54 | 97.88 | 47.61 |
| Cash Conversion Cycle | 153.88 | 153.88 | 254.34 | 282.25 | 237.77 | 240.36 |
| Working Capital Days | -164.03 | -163.20 | -105.26 | -14.00 | 109.33 | 120.13 |
| ROCE % | 5.77% | -2.89% | 3.69% | 6.06% | 12.78% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 |
|---|---|---|
| FaceValue | 10.00 | 10.00 |
| Basic EPS (Rs.) | 5.24 | 1.22 |
| Diluted EPS (Rs.) | 5.24 | 1.22 |
| Cash EPS (Rs.) | 8.60 | 4.50 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 45.84 | 40.61 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 45.84 | 40.61 |
| Revenue From Operations / Share (Rs.) | 71.62 | 49.60 |
| PBDIT / Share (Rs.) | 11.29 | 6.66 |
| PBIT / Share (Rs.) | 7.93 | 3.25 |
| PBT / Share (Rs.) | 6.42 | 0.92 |
| Net Profit / Share (Rs.) | 5.24 | 1.09 |
| NP After MI And SOA / Share (Rs.) | 5.24 | 1.09 |
| PBDIT Margin (%) | 15.76 | 13.41 |
| PBIT Margin (%) | 11.07 | 6.54 |
| PBT Margin (%) | 8.96 | 1.86 |
| Net Profit Margin (%) | 7.31 | 2.19 |
| NP After MI And SOA Margin (%) | 7.31 | 2.19 |
| Return on Networth / Equity (%) | 11.42 | 2.68 |
| Return on Capital Employeed (%) | 15.05 | 6.57 |
| Return On Assets (%) | 7.38 | 1.57 |
| Long Term Debt / Equity (X) | 0.14 | 0.21 |
| Total Debt / Equity (X) | 0.38 | 0.47 |
| Current Ratio (X) | 2.54 | 2.21 |
| Quick Ratio (X) | 1.24 | 1.07 |
| Interest Coverage Ratio (X) | 7.47 | 2.87 |
| Interest Coverage Ratio (Post Tax) (X) | 4.46 | 1.47 |
| Enterprise Value (Cr.) | 78.34 | 130.32 |
| EV / Net Operating Revenue (X) | 1.52 | 3.65 |
| EV / EBITDA (X) | 9.64 | 27.21 |
| MarketCap / Net Operating Revenue (X) | 1.34 | 3.45 |
| Price / BV (X) | 2.09 | 4.21 |
| Price / Net Operating Revenue (X) | 1.34 | 3.45 |
| EarningsYield | 0.05 | 0.01 |
After reviewing the key financial ratios for Alkosign Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 5.24. This value is within the healthy range. It has increased from 1.22 (Mar 24) to 5.24, marking an increase of 4.02.
- For Diluted EPS (Rs.), as of Mar 25, the value is 5.24. This value is within the healthy range. It has increased from 1.22 (Mar 24) to 5.24, marking an increase of 4.02.
- For Cash EPS (Rs.), as of Mar 25, the value is 8.60. This value is within the healthy range. It has increased from 4.50 (Mar 24) to 8.60, marking an increase of 4.10.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 45.84. It has increased from 40.61 (Mar 24) to 45.84, marking an increase of 5.23.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 45.84. It has increased from 40.61 (Mar 24) to 45.84, marking an increase of 5.23.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 71.62. It has increased from 49.60 (Mar 24) to 71.62, marking an increase of 22.02.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 11.29. This value is within the healthy range. It has increased from 6.66 (Mar 24) to 11.29, marking an increase of 4.63.
- For PBIT / Share (Rs.), as of Mar 25, the value is 7.93. This value is within the healthy range. It has increased from 3.25 (Mar 24) to 7.93, marking an increase of 4.68.
- For PBT / Share (Rs.), as of Mar 25, the value is 6.42. This value is within the healthy range. It has increased from 0.92 (Mar 24) to 6.42, marking an increase of 5.50.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 5.24. This value is within the healthy range. It has increased from 1.09 (Mar 24) to 5.24, marking an increase of 4.15.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 5.24. This value is within the healthy range. It has increased from 1.09 (Mar 24) to 5.24, marking an increase of 4.15.
- For PBDIT Margin (%), as of Mar 25, the value is 15.76. This value is within the healthy range. It has increased from 13.41 (Mar 24) to 15.76, marking an increase of 2.35.
- For PBIT Margin (%), as of Mar 25, the value is 11.07. This value is within the healthy range. It has increased from 6.54 (Mar 24) to 11.07, marking an increase of 4.53.
- For PBT Margin (%), as of Mar 25, the value is 8.96. This value is below the healthy minimum of 10. It has increased from 1.86 (Mar 24) to 8.96, marking an increase of 7.10.
- For Net Profit Margin (%), as of Mar 25, the value is 7.31. This value is within the healthy range. It has increased from 2.19 (Mar 24) to 7.31, marking an increase of 5.12.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 7.31. This value is below the healthy minimum of 8. It has increased from 2.19 (Mar 24) to 7.31, marking an increase of 5.12.
- For Return on Networth / Equity (%), as of Mar 25, the value is 11.42. This value is below the healthy minimum of 15. It has increased from 2.68 (Mar 24) to 11.42, marking an increase of 8.74.
- For Return on Capital Employeed (%), as of Mar 25, the value is 15.05. This value is within the healthy range. It has increased from 6.57 (Mar 24) to 15.05, marking an increase of 8.48.
- For Return On Assets (%), as of Mar 25, the value is 7.38. This value is within the healthy range. It has increased from 1.57 (Mar 24) to 7.38, marking an increase of 5.81.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.14. This value is below the healthy minimum of 0.2. It has decreased from 0.21 (Mar 24) to 0.14, marking a decrease of 0.07.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.38. This value is within the healthy range. It has decreased from 0.47 (Mar 24) to 0.38, marking a decrease of 0.09.
- For Current Ratio (X), as of Mar 25, the value is 2.54. This value is within the healthy range. It has increased from 2.21 (Mar 24) to 2.54, marking an increase of 0.33.
- For Quick Ratio (X), as of Mar 25, the value is 1.24. This value is within the healthy range. It has increased from 1.07 (Mar 24) to 1.24, marking an increase of 0.17.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 7.47. This value is within the healthy range. It has increased from 2.87 (Mar 24) to 7.47, marking an increase of 4.60.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.46. This value is within the healthy range. It has increased from 1.47 (Mar 24) to 4.46, marking an increase of 2.99.
- For Enterprise Value (Cr.), as of Mar 25, the value is 78.34. It has decreased from 130.32 (Mar 24) to 78.34, marking a decrease of 51.98.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.52. This value is within the healthy range. It has decreased from 3.65 (Mar 24) to 1.52, marking a decrease of 2.13.
- For EV / EBITDA (X), as of Mar 25, the value is 9.64. This value is within the healthy range. It has decreased from 27.21 (Mar 24) to 9.64, marking a decrease of 17.57.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.34. This value is within the healthy range. It has decreased from 3.45 (Mar 24) to 1.34, marking a decrease of 2.11.
- For Price / BV (X), as of Mar 25, the value is 2.09. This value is within the healthy range. It has decreased from 4.21 (Mar 24) to 2.09, marking a decrease of 2.12.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.34. This value is within the healthy range. It has decreased from 3.45 (Mar 24) to 1.34, marking a decrease of 2.11.
- For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.05, marking an increase of 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Alkosign Ltd:
- Net Profit Margin: 7.31%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 15.05% (Industry Average ROCE: 11.73%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 11.42% (Industry Average ROE: 22.92%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 4.46
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.24
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 23.2 (Industry average Stock P/E: 398.29)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.38
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 7.31%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Printing/Publishing/Stationery | Plot No. 12-A, Kalyan Bhiwandi Industrial Area, Thane Maharashtra 421311 | investor@alkosign.com https://www.alkosign.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Samir Narendra Shah | Chairman & Managing Director |
| Mr. Shrenik Kamlesh Shah | Whole Time Director |
| Mr. Akshay Narendra Shah | Non Executive Director |
| Ms. Zeenal Shrenik Shah | Non Executive Director |
| Mr. Parshva Vinaykant Doshi | Ind. Non-Executive Director |
| Mr. Yogesh Ramgopal Gupta | Ind. Non-Executive Director |
| Ms. Seema Ashim Jhaveri | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Alkosign Ltd?
Alkosign Ltd's intrinsic value (as of 10 October 2025) is 69.52 which is 13.10% lower the current market price of 80.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹86.3 Cr. market cap, FY2025-2026 high/low of 96.7/46.0, reserves of ₹25.79 Cr, and liabilities of 51.05 Cr.
What is the Market Cap of Alkosign Ltd?
The Market Cap of Alkosign Ltd is 86.3 Cr..
What is the current Stock Price of Alkosign Ltd as on 10 October 2025?
The current stock price of Alkosign Ltd as on 10 October 2025 is 80.0.
What is the High / Low of Alkosign Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Alkosign Ltd stocks is 96.7/46.0.
What is the Stock P/E of Alkosign Ltd?
The Stock P/E of Alkosign Ltd is 23.2.
What is the Book Value of Alkosign Ltd?
The Book Value of Alkosign Ltd is 30.6.
What is the Dividend Yield of Alkosign Ltd?
The Dividend Yield of Alkosign Ltd is 0.00 %.
What is the ROCE of Alkosign Ltd?
The ROCE of Alkosign Ltd is 12.8 %.
What is the ROE of Alkosign Ltd?
The ROE of Alkosign Ltd is 12.0 %.
What is the Face Value of Alkosign Ltd?
The Face Value of Alkosign Ltd is 10.0.